Newcelx Stock Performance
| NCEL Stock | 3.09 0.32 11.55% |
The company secures a Beta (Market Risk) of 1.0, which conveys possible diversification benefits within a given portfolio. NewcelX returns are very sensitive to returns on the market. As the market goes up or down, NewcelX is expected to follow. At this point, NewcelX has a negative expected return of -0.13%. Please make sure to verify NewcelX's value at risk, accumulation distribution, as well as the relationship between the Accumulation Distribution and day typical price , to decide if NewcelX performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days NewcelX has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's technical and fundamental indicators remain persistent and the latest mess on Wall Street may also be a sign of long-standing gains for the company institutional investors. ...more
Actual Historical Performance (%)
One Day Return (6.47) | Five Day Return 8.24 | Year To Date Return 38.28 | Ten Year Return (99.75) | All Time Return (99.75) |
1 | NewcelX Announces Updated Corporate Presentation Ahead of Key Spring 2026 Investor and Partnering Conferences | 01/29/2026 |
| Begin Period Cash Flow | 897.7 K | |
| Total Cashflows From Investing Activities | -3917.00 | |
| Free Cash Flow | -4.3 M |
NewcelX Relative Risk vs. Return Landscape
If you would invest 368.00 in NewcelX on November 12, 2025 and sell it today you would lose (79.00) from holding NewcelX or give up 21.47% of portfolio value over 90 days. NewcelX is currently does not generate positive expected returns and assumes 7.3407% risk (volatility on return distribution) over the 90 days horizon. In different words, 65% of stocks are less volatile than NewcelX, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
NewcelX Target Price Odds to finish over Current Price
The tendency of NewcelX Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 3.09 | 90 days | 3.09 | about 47.31 |
Based on a normal probability distribution, the odds of NewcelX to move above the current price in 90 days from now is about 47.31 (This NewcelX probability density function shows the probability of NewcelX Stock to fall within a particular range of prices over 90 days) .
NewcelX Price Density |
| Price |
Predictive Modules for NewcelX
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as NewcelX. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of NewcelX's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
NewcelX Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. NewcelX is not an exception. The market had few large corrections towards the NewcelX's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold NewcelX, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of NewcelX within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.73 | |
β | Beta against Dow Jones | 1.00 | |
σ | Overall volatility | 0.74 | |
Ir | Information ratio | -0.1 |
NewcelX Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of NewcelX for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for NewcelX can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| NewcelX generated a negative expected return over the last 90 days | |
| NewcelX has high historical volatility and very poor performance | |
| NewcelX has a very high chance of going through financial distress in the upcoming years | |
| NewcelX was previously known as NLS Pharmaceutics AG and was traded on NASDAQ Exchange under the symbol NLSP. | |
| Net Loss for the year was (1.98 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| NewcelX generates negative cash flow from operations | |
| NewcelX has a frail financial position based on the latest SEC disclosures | |
| Latest headline from finance.yahoo.com: NewcelX Announces Updated Corporate Presentation Ahead of Key Spring 2026 Investor and Partnering Conferences |
NewcelX Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of NewcelX Stock often depends not only on the future outlook of the current and potential NewcelX's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. NewcelX's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 154.3 K | |
| Cash And Short Term Investments | 1.7 M |
NewcelX Fundamentals Growth
NewcelX Stock prices reflect investors' perceptions of the future prospects and financial health of NewcelX, and NewcelX fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on NewcelX Stock performance.
| EBITDA | (3.63 M) | ||||
| Net Income | (1.98 M) | ||||
| Total Debt | 28.18 M | ||||
| Cash Flow From Operations | (4.27 M) | ||||
| Total Asset | 2.23 M | ||||
| Retained Earnings | (74.43 M) | ||||
| Working Capital | (29.6 M) | ||||
About NewcelX Performance
By examining NewcelX's fundamental ratios, stakeholders can obtain critical insights into NewcelX's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that NewcelX is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | -1.2 K | -1.2 K | |
| Return On Tangible Assets | (1.02) | (1.07) | |
| Return On Capital Employed | (2.80) | (2.66) | |
| Return On Assets | (1.02) | (1.07) | |
| Return On Equity | (1.62) | (1.70) |
Things to note about NewcelX performance evaluation
Checking the ongoing alerts about NewcelX for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for NewcelX help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| NewcelX generated a negative expected return over the last 90 days | |
| NewcelX has high historical volatility and very poor performance | |
| NewcelX has a very high chance of going through financial distress in the upcoming years | |
| NewcelX was previously known as NLS Pharmaceutics AG and was traded on NASDAQ Exchange under the symbol NLSP. | |
| Net Loss for the year was (1.98 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| NewcelX generates negative cash flow from operations | |
| NewcelX has a frail financial position based on the latest SEC disclosures | |
| Latest headline from finance.yahoo.com: NewcelX Announces Updated Corporate Presentation Ahead of Key Spring 2026 Investor and Partnering Conferences |
- Analyzing NewcelX's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether NewcelX's stock is overvalued or undervalued compared to its peers.
- Examining NewcelX's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating NewcelX's management team can have a significant impact on its success or failure. Reviewing the track record and experience of NewcelX's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of NewcelX's stock. These opinions can provide insight into NewcelX's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in NewcelX. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in discontinued. For more information on how to buy NewcelX Stock please use our How to buy in NewcelX Stock guide.You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of NewcelX. Anticipated expansion of NewcelX directly elevates investor willingness to pay premium valuations. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive NewcelX assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Investors evaluate NewcelX using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating NewcelX's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. External factors like market trends, sector rotation, and investor psychology can cause NewcelX's market price to deviate significantly from intrinsic value.
It's important to distinguish between NewcelX's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding NewcelX should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, NewcelX's market price signifies the transaction level at which participants voluntarily complete trades.